Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adelco is a long-established Greek pharmaceutical and cosmetics manufacturer focused on development, licensing, manufacturing, marketing, and distribution of branded generics, combination pharmaceuticals, and consumer health products. The company operates an EU-GMP-certified, vertically integrated manufacturing site in Moschato, Athens, and produces a broad range of dosage forms including tablets, capsules, syrups, creams, gels, ear drops, and terminally sterilized ampoules. In addition to its own marketed prescription and non-prescription products, Adelco provides contract manufacturing and product-development services for pharmaceutical and cosmetic partners. The business also maintains international commercial activity across Eastern Europe, North Africa, the Middle East, Far East, and Oceania, with representative presence in Jordan and Australia. Adelco appears to be a commercial-stage specialty manufacturer and marketer rather than a venture-stage therapeutics developer with a disclosed R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adelco.